CMC Writing Support Helps Client Lift Clinical Hold
In drug development, Chemistry, Manufacturing, and Controls (CMC) regulatory writing plays a pivotal role in ensuring the…
CertaraDecember 10, 2024
Piet van der Graaf on AI and AI-assisted approaches in drug discovery & development
At the 2024 AAPS PharmSci 360 conference, Bioanalysis Zone interviewed Piet van der Graaf, Senior…
CertaraDecember 10, 2024
Advancing pharmacometrics in Africa – Transition from capacity development toward job creation
This CPT article showcases, the Applied Pharmacometrics Training (APT) program, launched in 2021 by Pharmacometrics…
CertaraDecember 9, 2024
Sneak Preview: Introducing TFL Studio
Get your preview of the upcoming Tables, Figures, and Listings (TFL) Module in Phoenix Cloud.…
CertaraDecember 5, 2024
Key development considerations for cell therapies
December 5, 2024 What is a “cell therapy”? Nearly every recent oncology clinical conference has…
CertaraDecember 5, 2024
Quantitative Systems Pharmacology-Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease
Pompe disease is a rare and complex condition with severe infantile-onset (IOPD) and late-onset (LOPD)…
CertaraDecember 4, 2024
GlobalSubmit eCTD 4.0 Webinars
The world of electronic regulatory submissions is about to change with the introduction of eCTD…
CertaraDecember 3, 2024
CDISC SEND V3.1.1 Updates Nonclinical Drug Developers Need to Know
December 3, 2024 The Standard for Exchange of Nonclinical Data (SEND) is a standardized, electronic format for…
CertaraDecember 3, 2024
Certara Showcases 2024 Research Wins with Over 100 Papers Published
The company celebrates the 12 scientists included in the Stanford/Elsevier top 2% cited researchers list …
CertaraDecember 2, 2024
